AMA says government should negotiate drug prices

10/18/2004 | NYTimes.com

The American Medical Association says Congress should give the HHS the authority to negotiate contracts with drug manufacturers covered under the new Medicare prescription drug law. Currently the Medicare law says the government "may not interfere" in those negotiations with drug companies. The AMA said some agencies within the federal government have saved substantial dollars for their beneficiaries and that other medical services have long been under government-imposed fee limits.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA